Cross, Anne H.; Delgado, Silvia; Habek, Mario; Davydovskaya, Maria; Ward, Brian J.; Cree, Bruce A. C.; Totolyan, Natalia; Pingili, Ratnakar; Mancione, Linda; Hu, Xixi; Sullivan, Roseanne; Su, Wendy; Zielman, Ronald; Gupta, Ayan Das; Montalban, Xavier; Winthrop, KevinViše autora...
Citirajte ovaj rad
Cross, A. H., Delgado, S., Habek, M., Davydovskaya, M., Ward, B. J., Cree, B. A. C. ... Winthrop, K. (2022). COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab. Neurology and Therapy, 11. (2), 741-758. doi: 10.1007/s40120-022-00341-z
Cross, Anne H., et al. "COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab." Neurology and Therapy, vol. 11, br. 2, 2022, str. 741-758. https://doi.org/10.1007/s40120-022-00341-z
Cross, Anne H., Silvia Delgado, Mario Habek, Maria Davydovskaya, Brian J. Ward, Bruce A. C. Cree, Natalia Totolyan, et al. "COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab." Neurology and Therapy 11, br. 2 (2022): 741-758. https://doi.org/10.1007/s40120-022-00341-z
Cross, A. H., et al. (2022) 'COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab', Neurology and Therapy, 11(2), str. 741-758. doi: 10.1007/s40120-022-00341-z
Cross AH, Delgado S, Habek M, Davydovskaya M, Ward BJ, Cree BAC, i sur.. COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab. Neurology and Therapy [Internet]. 06.2022. [pristupljeno 18.10.2024.];11(2):741-758. doi: 10.1007/s40120-022-00341-z
A. H. Cross, et al., "COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab", Neurology and Therapy, vol. 11, br. 2, str. 741-758, Lipanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:176399. [Citirano: 18.10.2024.]